- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
The Irving Institute for Clinical and Translational Research, home of the Columbia University CTSA Hub, is offering - TL1 Training Program Now Accepting Applications The TL1 Training Programs are intended to provide trainees with additional research training to prepare for a research career that can contribute in some meaningful way to understanding risk of disease, improving diagnosis and
The Irving Institute's Columbia Community Partnership for Health (CCPH), in partnership with the NYP Emergency Food Program, has been delivering groceries in upper Manhattan to 890 families each month during the COVID-19 pandemic. Watch the amazing community effort and impact that has resulted: https://vimeo.com/471555431
Mitochondrial diseases affect approximately 1 in every 5,000 people. These diseases can cause muscle weakness, difficulty thinking, seizures, hearing and vision loss, digestive problems, learning disabilities, and organ failure. The North American Mitochondrial Disease Consortium (NAMDC) is a network of clinicians and researchers at 17 different clinical sites working to better understand
Focal and Segmental Glomerulosclerosis, Minimal Change Disease and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in the
The Columbia University CTSA KL2 program is honored to be highlighted as one of the top program hubs by the Center for Leading Innovation and Collaboration (CLIC). The CU program has demonstrated significant improvements in the Careers in Clinical & Translational Research Common Metric within the KL2 women’s measure. The CLIC Common Metrics Initiative team collects and reports annual data, and
Now accepting pre-proposals to the 2020-2021 Columbia Life Science Accelerators.
We’re thrilled to join forces with @HHPHorg for #20SegundosOMas Together with Olajide Williams, the President and Founder of Hip Hop for Health, and faculty of the Columbia University CTSA Hub, this PSA features over 30 community influencers and activists who represent the full depth, breadth and diversity of the Latino diaspora. In just a few hours it had already reached an audience of more than
The New York and Connecticut Consortium encourages joint ventures among the New York and Connecticut area CTSA institutions (NYCON) to develop collaboration between CTSA programs in the areas of medical scientist training; the creation of regional databases of facilities; regional training opportunities for investigators and research coordinators; the exploration of barriers to improved social
These stand-alone workshops precede the May 6th-7th conference for best practices in representation & reasoning. The workshops have separate calls for papers and their own program and organizing committee. The tutorials are half-day learning sessions that include both lecture style and hands-on sessions. Early bird registration ends Feb 15, 2020!
Precision medicine has arrived, but many physicians do not have the training or time to incorporate genetic sequencing technologies into everyday practice. In two new articles published online in the Annals of Internal Medicine, precision medicine experts at Columbia University Vagelos College of Physicians and Surgeons and Co-Directors of the Irving Institute’s Precision Medicine Resource, Drs
A genomic incompatibility could explain why many kidney transplants fail, even when donors and recipients are thought to be well-matched, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggests. The co-senior author is Dr. Krzysztof Kiryluk, Herbert Irving Assistant Professor of Medicine and Co-Director of the Irving Institute’s Precision Medicine
The Irving Institute for Clinical and Translational Research, home to Columbia University’s CTSA Program Hub, provides resources to investigators in the areas of precision medicine and translational research through two unique resources focused on providing funding, education, research services, and mentorship programs to support advancement of projects. The Translational Therapeutics (TRx)